Friday 22nd September 2023 |
Text too small? |
Amended Capital Change Notice to reflect the correct total number of Financial Products of the Class after the issue/acquisition/redemption/Conversion (excluding Treasury Stock) being 715,265,270 ordinary shares (excluding Treasury Stock).
Section 1: Issuer information
Name of issuer: Heartland Group Holdings Limited
NZX ticker code: HGH
Class of financial product: Ordinary shares
ISIN (If unknown, check on NZX website): NZHGHE0007S9
Currency: NZD
Section 2: Capital change details
Number issued/acquired/redeemed: 4,790,946
Nominal value (if any): N/A
Issue/acquisition/redemption price per security: $1.68653026
Nature of the payment (for example, cash or other consideration): Consideration satisfied pursuant to the Dividend Reinvestment Plan
Amount paid up (if not in full): Fully paid ordinary shares
Percentage of total class of Financial Products issued/acquired/redeemed/ (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence): 0.67% of the total number of fully paid ordinary shares prior to this issue
For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date): N/A
Reason for issue/acquisition/redemption and specific authority for issue/acquisition/redemption/ (the reason for change must be identified here): Issue of ordinary shares to those shareholders that have elected to participate in the HGH Dividend Reinvestment Plan, approved by directors’ resolutions.
Total number of Financial Products of the Class after the issue/acquisition/redemption/Conversion (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue/acquisition/redemption: 715,265,270 ordinary shares (excluding Treasury Stock); 459,070 Treasury Stock
In the case of an acquisition of shares, whether those shares are to be held as treasury stock:N/A
Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made:Directors’ resolution
Issue of Ordinary Shares under Listing Rule 4.8.1
Terms or details of the issue, acquisition, or redemption (for example: restrictions, escrow arrangements): Pursuant to the terms of the HGH Dividend Reinvestment Plan Offer Document dated 10 December 2018
Date of issue/acquisition/redemption: 20 September 2023
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement: Andrew Dixson, Chief Financial Officer
Contact person for this announcement: Nicola Foley, Group Head of Communications
Contact phone number: 027 345 6809
Contact email address: Nicola.Foley@heartland.co.nz
Date of release through MAP: 22/09/2023
No comments yet
Second St John withdrawal of labour takes effect tomorrow with further strikes likely
Sanford Appoints Independent Director
CRP ADVISES CLOSURE OF SHARE OFFER TO EXISTING INVESTOR
Devon Funds Morning Note - 14 August 2024
OCR 5.25% - Monetary restraint tempered as inflation converges on target
Consumers still need due diligence as new deposit takers emerge.
Woolworths strike: staff asked to dress up in Disney costumes for a week on their own dollar
Turners Invests in Quashed Online Insurance Platform
PGW Reports on Challenging Year
Arvida Announces Executive Team Changes